An Open-Label, Proof of Concept, Efficacy, Safety and Tolerability Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Prevention and Treatment of Oral Mucositis Induced by Radiation Therapy
Phase of Trial: Phase II
Latest Information Update: 09 Nov 2017
At a glance
- Drugs Santalum album (Primary)
- Indications Stomatitis
- Focus Proof of concept; Therapeutic Use
- Sponsors Santalis Pharmaceuticals
- 19 Jun 2017 Status changed from recruiting to completed.
- 24 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 Jun 2017.
- 24 Apr 2017 Planned primary completion date changed from 1 Jan 2017 to 1 May 2017.